This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Mar 8;366(10):957-9.

doi: 10.1056/NEJMe1200429.

Discontinuing donepezil or starting memantine for Alzheimer's disease

Lon S Schneider

PMID: 22397659
DOI: 10.1056/NEJMe1200429

Editorial

Discontinuing donepezil or starting memantine for Alzheimer's disease

Lon S Schneider. N Engl J Med. 2012.

. 2012 Mar 8;366(10):957-9.

doi: 10.1056/NEJMe1200429.

Author

Lon S Schneider

PMID: 22397659
DOI: 10.1056/NEJMe1200429

No abstract available

PubMed Disclaimer

Comment on

Donepezil and memantine for moderate-to-severe Alzheimer's disease.
Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Passmore P, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown R, Banerjee S, Onions C, Griffin M, Adams J, Gray R, Johnson T, Bentham P, Phillips P. Howard R, et al. N Engl J Med. 2012 Mar 8;366(10):893-903. doi: 10.1056/NEJMoa1106668. N Engl J Med. 2012. PMID: 22397651 Clinical Trial.

Similar articles

Discontinuing donepezil or starting memantine for Alzheimer's disease.
Suzuki T. Suzuki T. N Engl J Med. 2012 Jun 7;366(23):2227-8; author reply 2228. doi: 10.1056/NEJMc1204656. N Engl J Med. 2012. PMID: 22670911 No abstract available.
Discontinuing donepezil or starting memantine for Alzheimer's disease.
Finucane MM, Finucane TE. Finucane MM, et al. N Engl J Med. 2012 Jun 7;366(23):2227-8; author reply 2228. doi: 10.1056/NEJMc1204656. N Engl J Med. 2012. PMID: 22670912 No abstract available.
Cessation of donepezil is associated with clinical decline in patients with moderate-to-severe Alzheimer's disease compared to continuation of donepezil or addition or substitution of memantine.
Tariot PN. Tariot PN. Evid Based Med. 2013 Apr;18(2):62-3. doi: 10.1136/eb-2012-100722. Epub 2012 Jun 26. Evid Based Med. 2013. PMID: 22736656 No abstract available.
New drugs for Alzheimer's disease in Japan.
Takeda M, Tanaka T, Okochi M. Takeda M, et al. Psychiatry Clin Neurosci. 2011 Aug;65(5):399-404. doi: 10.1111/j.1440-1819.2011.02253.x. Psychiatry Clin Neurosci. 2011. PMID: 21851448 Review. No abstract available.
[Memantine (Ebixa), glutaminergic modulator].
Sternon J, Bier JC. Sternon J, et al. Rev Med Brux. 2004 Apr;25(2):93-7. Rev Med Brux. 2004. PMID: 15157062 Review. French.

See all similar articles

Cited by

Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey.
Vardigan JD, Cannon CE, Puri V, Dancho M, Koser A, Wittmann M, Kuduk SD, Renger JJ, Uslaner JM. Vardigan JD, et al. Psychopharmacology (Berl). 2015 Jun;232(11):1859-66. doi: 10.1007/s00213-014-3813-x. Epub 2014 Dec 10. Psychopharmacology (Berl). 2015. PMID: 25491927
Patterns and determinants of dementia pharmacotherapy in a population-based cohort of home care clients.
Maxwell CJ, Vu M, Hogan DB, Patten SB, Jantzi M, Kergoat MJ, Jetté N, Bronskill SE, Heckman G, Hirdes JP. Maxwell CJ, et al. Drugs Aging. 2013 Jul;30(7):569-85. doi: 10.1007/s40266-013-0083-y. Drugs Aging. 2013. PMID: 23605786
Alzheimer disease pharmacologic treatment and treatment research.
Schneider LS. Schneider LS. Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):339-57. doi: 10.1212/01.CON.0000429180.60095.d0. Continuum (Minneap Minn). 2013. PMID: 23558481 Free PMC article. Review.
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.
Noetzli M, Eap CB. Noetzli M, et al. Clin Pharmacokinet. 2013 Apr;52(4):225-41. doi: 10.1007/s40262-013-0038-9. Clin Pharmacokinet. 2013. PMID: 23408070 Review.
Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study.
Colloca G, Tosato M, Vetrano DL, Topinkova E, Fialova D, Gindin J, van der Roest HG, Landi F, Liperoti R, Bernabei R, Onder G; SHELTER project. Colloca G, et al. PLoS One. 2012;7(10):e46669. doi: 10.1371/journal.pone.0046669. Epub 2012 Oct 3. PLoS One. 2012. PMID: 23056394 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information